NCT03432689View on ClinicalTrials.gov

Cycloserine rTMS Plasticity Augmentation

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 6, 2018

Primary Completion Date

November 7, 2018

Study Completion Date

November 7, 2018

Conditions
Motor Activity
Interventions
DEVICE

Transcranial Magnetic Stimulation

Single-pulse transcranial magnetic stimulation and theta-burst stimulation

DRUG

Cycloserine

Cycloserine 100mg

DRUG

Placebo Oral Tablet

Placebo capsule matched to cycloserine capsule

Trial Locations (1)

T2N1N4

University of Calgary, Calgary

All Listed Sponsors
lead

University of Calgary

OTHER

NCT03432689 - Cycloserine rTMS Plasticity Augmentation | Biotech Hunter | Biotech Hunter